Month: December 2012

Manolis Kogevinas: ”Circadian rhythm disruption increases cancer risk”

The circadian rhythm is related with various diseases, including some cancers such as breast and prostate cancers. Manolis Kogevinas, researcher at the Centre for Research in Environmental Epidemiology (CREAL), warned of the risks to health of altering the biological rhythm, during an IDIBELL seminar held in the conference hall Pau Viladiu, at the Duran I …

Manolis Kogevinas: ”Circadian rhythm disruption increases cancer risk” Read More »

Good oral health reduces the risk of muscle injury

Maintaining a proper oral health is essential to prevent or minimize the risk of muscle injury in elite athletes. This is the main conclusion of the study leaded by Dr. Cosme Gay Escoda, researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and the medical team of FC Barcelona. For three seasons, from 2003 to 2006, …

Good oral health reduces the risk of muscle injury Read More »

Researchers describe a key mechanism in muscle regeneration

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have described a new selectively target in muscle regeneration. This is the association of alpha-enolase protein and plasmin. The finding could be used to develop new treatments to regenerate muscular injuries or dystrophies. The study was published in the PLOS ONE journal. Skeletal muscle has a great …

Researchers describe a key mechanism in muscle regeneration Read More »

Janet Treasure: ”The eating disorder becomes the only friend of the patients”

The eating behavior disorders are complex problems that involve genetic, environmental and family. The Director of the Eating Disorders Service at South London & Maudsley NHS Foundation Trust and Professor of Psychiatry at Guy’s, King’s & St Thomas’ School of Medicine, London, Janet Treasure, gave a lecture on these ever more prevalent diseases in the …

Janet Treasure: ”The eating disorder becomes the only friend of the patients” Read More »

Sònia Forcales: “BAF60c plays an essential role for myogenic differentiation”

The conference “BAF60c-MyoD complex poises chromatin for myogenic differentiation” by Dr. Sònia Forcales, from the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), which took place on November 22th in the Auditorium of the University of Barcelona (Campus Bellvitge) focused on the role of BAF60c in muscle and muscular dystrophy differentiation. Dr. Forcades talked …

Sònia Forcales: “BAF60c plays an essential role for myogenic differentiation” Read More »

Fernando Fernandez Aranda: ”eating disorders are not nutritional problems, but mental problems”

Eating behaviour disorders are not mental but nutritional problems. Although it has been repeated many times in television series, reports and journal articles, it seems that not everyone is quite clear about this fact, judging from the face of disbelief of some of those attending the talk by Fernando Fernández Aranda at Centre Cultural Sant …

Fernando Fernandez Aranda: ”eating disorders are not nutritional problems, but mental problems” Read More »

Stopping cancerous cells flow promotes metastasis

Nine out of ten cancer deaths occur because of metastasis. This phenomenon happens when cancer cells break away from the original tumour and spread through the body anchoring to other organs and form new tumours. IDIBELL researchers have participated in an investigation showing that Prrx1 protein prevents cancer cells lodge in other organs and, therefore, …

Stopping cancerous cells flow promotes metastasis Read More »

IDIBELL licenses to Janus a patent for the treatment of immune diseases

The Bellvitge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the company Janus Developments of a patent for an immunomodulatory product for treating immune diseases such as autoimmune diseases, sepsis, hypersensitivity disorders (including, allergic reactions) or post-transplant rejection. The patent has been developed by the researcher of the Human Molecular Genetics group Josep …

IDIBELL licenses to Janus a patent for the treatment of immune diseases Read More »

Scroll to Top